All Stories

  1. Evidence for uteroplacental malperfusion in fetuses with major congenital heart defects
  2. Role of prenatal magnetic resonance imaging in fetuses with isolated mild or moderate ventriculomegaly in the era of neurosonography: a multicenter study
  3. Diagnosis of fetal abnormalities using exome sequencing: translating research into practice
  4. Cesarean Scar Pregnancy Registry: an international research platform
  5. Ductus venosus Doppler waveform pattern in fetuses with early growth restriction
  6. The impact of gestational diabetes on maternal cardiac adaptation to pregnancy
  7. Maternal cardiovascular function and risk of intrapartum fetal compromise in women undergoing induction of labor: a pilot study
  8. Maternal arterial stiffness in hypertensive pregnancies with and without a small‐for‐gestational‐age neonate
  9. Consensus diagnostic criteria and monitoring of twin anemia polycythemia sequence: a Delphi procedure
  10. Influence of maternal characteristics and gestational age on hemodynamic indices: NICOM device‐specific reference ranges
  11. Early and late selective fetal growth restriction in monochorionic diamniotic twin pregnancies: natural history and diagnostic criteria
  12. Are maternal hemodynamic indices markers of fetal growth restriction in pregnancies with a small‐for‐gestational‐age fetus?
  13. Preeclampsia: The Relationship between Uterine Artery Blood Flow and Trophoblast Function
  14. Impact of ethnicity on adverse perinatal outcome in women with chronic hypertension: a cohort study
  15. Weight discordance and perinatal mortality in monoamniotic twin pregnancies: analysis of the MONOMONO, NorSTAMP and STORK multiple pregnancy cohorts
  16. Comparative analysis of the 2‐year outcomes in the GRIT and TRUFFLE trials
  17. Left ventricular torsional mechanics in term fetuses and neonates
  18. Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics
  19. Long‐term neuroimaging and neurological outcome of fetal spina bifida aperta after postnatal surgical repair
  20. Risk of operative delivery for intrapartum fetal compromise in small-for-gestational-age fetuses at term: external validation of the IRIS algorithm
  21. Perinatal outcome of monochorionic twin pregnancy complicated by selective fetal growth restriction according to management: systematic review and meta‐analysis
  22. Selective fetal growth restriction in monochorionic twin pregnancy: a dilemma for clinicians and a challenge for researchers
  23. Longitudinal change in the cerebroplacental ratio and the risk of stillbirth
  24. Maternal and perinatal outcomes after elective induction of labor at 39 weeks in uncomplicated singleton pregnancy: a meta‐analysis
  25. Perinatal changes in fetal cardiac geometry and function in gestational diabetic pregnancies at term
  26. Preeclampsia and the cardiovascular system: An update
  27. Cardiac maladaptation in obese pregnancy at term
  28. Placental thickness in the lower uterine segment and invasive placentation: Will the promise live up?
  29. Cardiac output measurements during high-risk caesarean section using electrical bioreactance or arterial wave form analysis: an assessment of agreement
  30. Lower uterine segment placental thickness in women with abnormally invasive placenta
  31. Prediction of adverse pregnancy outcome in monochorionic- diamniotic twin pregnancies complicated by selective fetal growth restriction
  32. Book: Genetics for obstetricians and gynaecologists
  33. Sensitivity of first-trimester ultrasound in the detection of congenital anomalies in twin pregnancies: population study and systematic review
  34. Mid-pregnancy fetal growth, uteroplacental Doppler indices and maternal demographic characteristics: role in prediction of stillbirth
  35. Mid-pregnancy fetal biometry, uterine artery Doppler indices and maternal demographic characteristics: role in prediction of small-for-gestational-age birth
  36. Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis
  37. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial
  38. Re: Maternal obesity and excess of fetal growth in pre-eclampsia
  39. Accuracy of Predicting Fetal Loss in Twin Pregnancies Using Gestational Age-Dependent Weight Discordance Cut-Offs: Analysis of the STORK Multiple Pregnancy Cohort
  40. Neonatal Acid-Base Status in Term Fetuses: Mathematical Models Investigating Cerebroplacental Ratio and Birth Weight
  41. Perioperative management and outcomes of aortic surgery during pregnancy
  42. Poor neonatal acid-base status in term fetuses with low cerebroplacental ratio
  43. Ushering in a new dawn in obstetrics and gynecology: the industry of cell-free DNA testing
  44. Fetal growth reference ranges in twin pregnancy: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort
  45. Cardiovascular Implications in Preeclampsia
  46. Reversible De Novo Left Ventricular Trabeculations in Pregnant Women
  47. Crown–rump length discordance and adverse perinatal outcome in twin pregnancies: systematic review and meta‐analysis
  48. Association between reduced fetal movements at term and first trimester markers of impaired placental development
  49. Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia
  50. Neurodevelopmental outcome in isolated mild fetal ventriculomegaly: systematic review and meta-analysis
  51. Ultrasound estimation of birth weight in twin pregnancy: comparison of biometry algorithms in the STORK multiple pregnancy cohort
  52. Widening of the femoral proximal diaphysis-metaphysis angle in fetuses with achondroplasia
  53. Fetal and placental vascular tumors: persistent fetal hyperdynamic status predisposes to poorer long-term neurodevelopmental outcome
  54. Association between reduced fetal movements at term and abnormal uterine artery Doppler indices
  55. First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55 974 women
  56. Outcome of first-trimester fetal abdominal cysts: cohort study and review of the literature
  57. Changes in fetal Doppler indices as a marker of failure to reach growth potential at term
  58. Multiple pregnancy: Preface
  59. Prenatal prediction of need for ventriculoperitoneal shunt in open spina bifida
  60. Twin pregnancy chorionicity determination in a tertiary care setting
  61. Brain abnormalities and neurodevelopmental delay in congenital heart disease: systematic review and meta-analysis
  62. Second-trimester discordance and adverse perinatal outcome in twins: the STORK multiple pregnancy cohort
  63. Comment on “First trimester uterine artery Doppler velocimetry in the prediction of birth weight in a low-risk population”
  64. Biparietal diameter at 11 to 13 weeks' gestation in fetuses with holoprosencephaly
  65. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial
  66. “Assisted” Reshaping of the Fetal Heart?
  67. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)
  68. Biparietal diameter at 11–13 weeks' gestation in fetuses with open spina bifida
  69. Value of adding second-trimester uterine artery Doppler to patient characteristics in identification of nulliparous women at increased risk for pre-eclampsia: an individual patient data meta-analysis
  70. Embryonic growth discordance and early fetal loss: the STORK multiple pregnancy cohort and systematic review
  71. Association between first‐trimester maternal serum pregnancy‐associated plasma protein‐A and obstetric complications
  72. Role of cerebroplacental ratio for fetal assessment in prolonged pregnancy
  73. Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis
  74. Crown-rump length discordance and adverse perinatal outcome in twins: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort
  75. Early fetal loss in monochorionic and dichorionic twin pregnancies: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort
  76. Weight discordance and perinatal mortality in twins: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort
  77. Does antenatal ultrasound labeling predict birth order in twin pregnancies?
  78. Trophoblast-Induced Changes in C-X-C Motif Chemokine 10 Expression Contribute to Vascular Smooth Muscle Cell Dedifferentiation During Spiral Artery Remodeling
  79. Comparison of Wavelet Transform and Time-Domain Analysis of Second Trimester Uterine Artery Doppler Waveforms in Screening for Pre-Eclampsia
  80. Cardiac structure and function in normal pregnancy
  81. Mid‐gestational maternal cardiovascular profile in preterm and term pre‐eclampsia: a prospective study
  82. Elective birth at 37 weeks of gestation versus standard care for women with an uncomplicated twin pregnancy at term: the Twins Timing of Birth Randomised Trial
  83. Counseling in fetal medicine: agenesis of the corpus callosum
  84. The diagnostic and therapeutic role of ultrasound in obstetrics
  85. Severe Myocardial Impairment and Chamber Dysfunction in Preterm Preeclampsia
  86. The effect of the contents of exomphalos and nuchal translucency at 11-14 weeks on the likelihood of associated chromosomal abnormality
  87. Prediction of Preeclampsia by Combining Serum Histidine-Rich Glycoprotein and Uterine Artery Doppler
  88. Neurodevelopmental delay in small babies at term: a systematic review
  89. Maternal Cardiovascular Impairment in Pregnancies Complicated by Severe Fetal Growth Restriction
  90. Impaired decidual natural killer cell regulation of vascular remodelling in early human pregnancies with high uterine artery resistance
  91. Mean, lowest, and highest pulsatility index of the uterine artery and adverse pregnancy outcome in twin pregnancies
  92. Corrections
  93. Relationship of first‐trimester uterine artery Doppler to late stillbirth
  94. Prospective risk of late stillbirth in monochorionic twins: a regional cohort study
  95. LEFT VENTRICULAR HYPERTRABECULATION IN AFRO-CARIBBEAN INDIVIDUALS: AN INHERITED CARDIOMYOPATHY OR A PHYSIOLOGICAL RESPONSE TO INCREASED CARDIAC PRELOAD
  96. A perfusion confusion?
  97. Prediction of selective fetal growth restriction and twin-to-twin transfusion syndrome in monochorionic twins
  98. Role of Second-Trimester Uterine Artery Doppler in Assessing Stillbirth Risk
  99. Screening for pre-eclampsia by using changes in uterine artery Doppler indices with advancing gestation
  100. Is first‐trimester crown–rump length associated with birthweight?
  101. Maternal cardiac function in preeclampsia
  102. Pregnancy Outcome of Monochorionic Twins: Does Amnionicity Matter?
  103. Antibiotic prophylaxis before amniocentesis
  104. The evidence base for miscarriage diagnosis: better late than never
  105. Preeclampsia Is Associated With Persistent Postpartum Cardiovascular Impairment
  106. Antenatal care for twin and triplet pregnancies: summary of NICE guidance
  107. Elevated glucocorticoid metabolism in placental tissue from first trimester pregnancies at increased risk of pre-eclampsia
  108. Systematic labeling of twin pregnancies on ultrasound
  109. Early prediction and prevention of pre-eclampsia
  110. Fetal hemoglobin and α1-microglobulin as first- and early second-trimester predictive biomarkers for preeclampsia
  111. First‐trimester ultrasound determination of chorionicity in twin pregnancy
  112. Uterine artery Doppler screening for pre-eclampsia: comparison of the lower, mean and higher first-trimester pulsatility indices
  113. Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies?
  114. Prevalence of maternal cardiac defects in women with high‐resistance uterine artery Doppler indices
  115. Prenatal diagnosis of non‐immune hydrops fetalis: what do we tell the parents?
  116. Maternal Cardiac Dysfunction and Remodeling in Women With Preeclampsia at Term
  117. Second‐trimester assessment of gestational age in twins: validation of singleton biometry charts
  118. Early pregnancy growth and pregnancy outcome in twin pregnancies
  119. Late termination of pregnancy and foetal reduction for foetal anomaly
  120. Early-Pregnancy Multiple Serum Markers and Second-Trimester Uterine Artery Doppler in Predicting Preeclampsia
  121. First-trimester ultrasound dating of twin pregnancy: are singleton charts reliable?
  122. Prenatal ultrasound in the prediction of bowel obstruction in infants with gastroschisis
  123. Prenatal findings and differential diagnosis of scimitar syndrome and pulmonary sequestration
  124. Sensitivity of higher, lower and mean second-trimester uterine artery Doppler resistance indices in screening for pre-eclampsia
  125. Giant placental chorioangioma: natural history and pregnancy outcome
  126. Cord entanglement and perinatal outcome in monoamniotic twin pregnancies
  127. The diagnostic and therapeutic role of ultrasound in obstetrics
  128. Guidelines for the management of postterm pregnancy
  129. Raised Maternal Serum Cystatin C: An Early Pregnancy Marker for Preeclampsia
  130. Relationship of intertwin crown-rump length discrepancy to chorionicity, fetal demise and birth-weight discordance
  131. First trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restriction
  132. First‐trimester uterine artery Doppler indices in the prediction of small‐for‐gestational age pregnancy and intrauterine growth restriction
  133. Association of Uterine Artery Doppler Resistance Index and Birth Weight: Effect of Customized Birth Weight Standards
  134. First trimester uterine artery Doppler in women with previous pre‐eclampsia
  135. Congenital vascular malformations: A series of five prenatally diagnosed cases
  136. First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia
  137. Outcome of Fetuses With Antenatally Diagnosed Short Femur
  138. Predictors of necrotizing enterocolitis in preterm growth-restricted neonates
  139. Outcome of fetuses with antenatally diagnosed short femur
  140. First‐trimester uterine artery resistance and maternal serum concentration of asymmetric dimethylarginine
  141. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin
  142. The prediction of intra-partum fetal compromise in prolonged pregnancy
  143. Ultrasound assessment of cervical length in prolonged pregnancy: prediction of spontaneous onset of labor and successful vaginal delivery
  144. Authors response to: Severe twin-twin transfusion syndrome: outcome after fetoscopic laser ablation of the placental vascular equator
  145. Computerized fetal heart rate analysis, Doppler ultrasound and biophysical profile score in the prediction of acid-base status of growth-restricted fetuses
  146. Outcome of antenatally diagnosed abdominal wall defects
  147. First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development
  148. Effect of heparin and fractionated heparin on trophoblast invasion
  149. Increased Apoptosis in First Trimester Extravillous Trophoblasts from Pregnancies at Higher Risk of Developing Preeclampsia
  150. Influence of parity on fetal mortality in prolonged pregnancy
  151. Severe twin-twin transfusion syndrome: outcome after fetoscopic laser ablation of the placental vascular equator
  152. Problem Based Obstetric Ultrasound
  153. MRI of the foetal brain
  154. Outcome of prenatally diagnosed agenesis of the corpus callosum
  155. Posterior fossa malformation in fetuses: a report of 56 further cases and a review of the literature
  156. The role of ultrasound in obstetrics
  157. Predictors of Neonatal Outcome in Early- Onset Placental Dysfunction
  158. First‐trimester uterine artery Doppler and spontaneous preterm delivery
  159. Maternal and neonatal outcome after failed ventouse delivery: Comparison of forceps versus cesarean section
  160. Prenatal diagnosis of segmental spinal dysgenesis
  161. Maternal cardiac function in early pregnancies with high uterine artery resistance
  162. Uterine artery Doppler velocimetry at 11–14 weeks in singleton pregnancies conceived by assisted reproductive technology
  163. Fetal surgical interventions
  164. Influence of parity on first trimester endovascular trophoblast invasion
  165. Do early pregnancy ultrasound measurements correlate with fetal nuchal translucency at 11–14 weeks?
  166. First-trimester nuchal translucency, nasal bones, and trisomy 21 in selected and unselected populations
  167. Effect of first-trimester serum from pregnant women with high-resistance uterine artery Doppler resistance on extravillous trophoblast invasion
  168. Effect of inter-twin delivery interval on neonatal haemoglobin concentration
  169. Effect of low dose heparin, unfractionated heparin and aspirin on trophoblast invasion
  170. Computerized fetal heart rate analysis (CCTG) for prediction of acidemia in fetal growth restriction (IUGR)
  171. Effect of serum from women with abnormal uterine artery Doppler resistance on extravillous trophoblast invasion in the first trimester
  172. Doppler and biophysical assessment in growth restricted fetuses: distribution of test results
  173. A newly described thoracic vascular malformation in fetuses with Down syndrome
  174. Neonatal outcome of antenatally diagnosed congenital cystic adenomatoid malformations
  175. First-Trimester Ductus Venosus, Nasal Bones, and Down Syndrome in a High-Risk Population
  176. The sensitivity of antenatal ultrasound for predicting renal tract surgery in early childhood
  177. Fetal congenital cardiac diverticulum with pericardial effusion: two cases with different presentations in the first trimester of pregnancy
  178. Natural history and outcome of prenatally diagnosed cystic hygroma
  179. Recent advances in the management of placenta previa
  180. Second‐trimester uterine artery Doppler and spontaneous preterm delivery
  181. Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies
  182. What prenatal diagnosis should be offered in multiple pregnancy?
  183. The Longitudinal Variation in Uterine Artery Blood Flow Pattern in Relation to Birth Weight
  184. Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices
  185. Viability in early-onset IUGR: is it time to reconsider intervention thresholds?
  186. Effect of parity on second‐trimester uterine artery Doppler flow velocity and waveforms
  187. Ultrasound-guided interstitial laser therapy for the treatment of placental chorioangioma
  188. Pre-natal diagnosis: structural anomalies
  189. First‐trimester uterine artery blood flow and birth weight
  190. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia
  191. Association between increased nuchal translucency and second trimester cardiac echogenic foci*1
  192. The role of oxytocin in parturition
  193. A newly recognized autosomal recessive syndrome with abnormal vertebral ossification, rib abnormalities, and nephrogenic rests
  194. Nuchal translucency thickness measurement: repeatability using a virtual ultrasound scanner
  195. Improving the effectiveness of routine prenatal screening for major congenital heart defects
  196. Prospective risk of stillbirth in multiple-gestation pregnancies: a population-based analysis
  197. Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening
  198. Comparison of feticide carried out by cordocentesis versus cardiac puncture
  199. Outcome of antenatally diagnosed talipes equinovarus in an unselected obstetric population
  200. Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus
  201. Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus
  202. Sensitivity and accuracy of routine antenatal ultrasound screening for isolated facial clefts
  203. Routine ultrasound for the prenatal diagnosis of congenital diaphragmatic hernia: the ‘isms’
  204. Fetal medicine: a liquid frontier
  205. Uterine artery resistance and anxiety in the second trimester of pregnancy
  206. The human ductus venosus between 13 and 17 weeks of gestation: histological and morphometric studies
  207. Reproducibility and repeatability of transabdominal uterine artery Doppler velocimetry between 10 and 14 weeks of gestation
  208. The anatomy of the umbilical, portal and hepatic venous systems in the human fetus at 14-19 weeks of gestation
  209. Significance of chromosome 22q11 analysis after detection of an increased first-trimester nuchal translucency
  210. The role of ultrasound in the expectant management of early pregnancy loss
  211. Fetal anemia as a consequence of hemorrhage into an ovarian cyst
  212. Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler
  213. Intraobserver and interobserver variability of transabdominal Doppler velocimetry measurements of the fetal ductus venosus between 10 and 14 weeks of gestation
  214. Role of ultrasound in obstetrics
  215. Natural history of fetal hydronephrosis diagnosed on mid-trimester ultrasound
  216. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects
  217. Increased nuchal translucency and normal karyotype: coping with uncertainty
  218. Antenatal diagnosis of fetal intra‐abdominal umbilical vein dilatation
  219. Sono-endoscopic delineation of the placental vascular equator prior to selective fetoscopic laser ablation in twin-to-twin transfusion syndrome
  220. Twin-to-twin transfusion syndrome - debates on the etiology, natural history and management
  221. Coping with winter bed crises
  222. Effectiveness of prenatal chromosomal analysis using multicolour fluorescent in situ hybridisation
  223. First trimester screening for fetal abnormalities
  224. First trimester nuchal translucency: effective routine screening for Down's syndrome.
  225. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population.
  226. First‐trimester nuchal translucency and maternal serum biochemical screening for Down's syndrome: a happy union?
  227. Influence of ethnic origin on nuchal translucency screening for Down's syndrome
  228. TRANSFER OF NUCLEATED MATERNAL CELLS INTO FETAL CIRCULATION DURING THE SECOND TRIMESTER OF PREGNANCY
  229. A nude mouse xenograft model to investigate slow cycling edidermal stem cells
  230. Relationship between fetal nuchal translucency thickness and second trimester maternal serum biochemistry
  231. Racial equity of screening for trisomy 21: comparison of nuchal translucency and maternal serum biochemistry
  232. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome
  233. Nuchal translucency: a marker for the antenatal diagnosis of aortic coarctation
  234. Maternal platelet size as a marker for fetal trisomies 18 and 13
  235. Neutrophil and monocyte β2-integrin expression in trisomic fetuses
  236. Blood transferrin receptor expression in chromosomally abnormal fetuses
  237. Neutrophil and monocyte β2-integrin expression in maternal and fetal blood
  238. Labor: An immunologically beneficial process for the neonate
  239. Fetal immunodeficiency: A consequence of placental insufficiency
  240. Platelet size and glycoprotein Ib and IIIa expression in normal fetal and maternal blood
  241. Predicting the severity of rhesus alloimmunization: monocyte-mediated chemiluminescence versus maternal anti-D antibody estimation
  242. Subpopulations of CD34‐positive haemopoietic progenitors in fetal blood
  243. Umbilical cord blood erythroblast count as an index of intrauterine hypoxia.
  244. Abnormal immunological development in fetuses with trisomy 18
  245. Fetal Blood Mononuclear Cell Division in Normal and Pathological Pregnancies
  246. Maternal Peripheral Blood Lymphocyte Subpopulations in Normal and Pathological Pregnancies
  247. Fetal plasma erythropoietin concentration in red blood cell‐isoimmunized pregnancies
  248. Fetal plasma interferon gamma concentration in normal pregnancy
  249. Abnormal fetal immunological development in Down's syndrome
  250. Fetal B Lymphocyte Subpopulations in Normal Pregnancies
  251. Management of the third stage of labour in women at low risk of postpartum haemorrhage
  252. Fetal plasma erythropoietin concentration in red blood cell-isoimmunized pregnancies
  253. Erythroblastosis in birth asphyxia
  254. Fetal and Maternal Erythropoietin Levels in Normal Pregnancy
  255. Cordocentesis in the investigation of fetal erythropoiesis
  256. Erythroblastosis and reticulocytosis in anemic fetuses
  257. Antenatal care for women with pre-existing medical, obstetric or mental health conditions